CompuGroup Medical Announces Share Buy-Back Program of Up to 500,000 Shares

CompuGroup Medical SE & Co. KGaA, as disclosed on March 25, 2024, has officially announced a share buy-back program. The plan involves the repurchase of up to 500,000 shares, equivalent to about 0.93% of its share capital. This move is pursuant to the authorization from its annual general meeting held on May 19, 2021, and aligns with the stipulations of the German Stock Corporation Act.

The allocated budget for this program is up to EUR 15,500,000, excluding transaction costs. A designated credit institution will execute the buy-back on the Frankfurt Stock Exchange adhering to the Market Abuse Regulation and associated laws, ensuring a fair and transparent process. The price per share will not deviate by more than 10% from the opening auction price on the trading day.

The share buy-back is scheduled between March 26, 2024, and April 28, 2024. These acquired shares may be utilized for any legally permissible purpose as defined by the 2021 general meeting authorization. The company will release additional details before the start of the buy-back process.